AR019482A1 - DERIVADOS SUSTITUIDOS DEL 2-IMIDAZO(5,1-b)TIAZOL-CARBAPENEM, LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS DERIVADOS PARA LAPREPARACION DE MEDICAMENTOS - Google Patents
DERIVADOS SUSTITUIDOS DEL 2-IMIDAZO(5,1-b)TIAZOL-CARBAPENEM, LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS DERIVADOS PARA LAPREPARACION DE MEDICAMENTOSInfo
- Publication number
- AR019482A1 AR019482A1 ARP990103683A ARP990103683A AR019482A1 AR 019482 A1 AR019482 A1 AR 019482A1 AR P990103683 A ARP990103683 A AR P990103683A AR P990103683 A ARP990103683 A AR P990103683A AR 019482 A1 AR019482 A1 AR 019482A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbapenem
- derivatives
- imidazo
- tiazol
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/18—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se revela un nuevo derivado de carbapenem que posee un grupo imidazo[5,1-b]tiazol sustituido en la posicion 2-en el anillo de carbapenem que posee una granactividad antimicrobiana contra las bacterias que porducen beta-lactamasa, MRSA, Pseudomonas aeruginosa resistente, PRSP, enterococos e influenza y, una granestabilidad a DHP-1. De acuerdo con la presente invencion, se proporciona un compuesto representado por la formula (1) o una sal farmacéuticamente aceptable deéste o un éster en la posicion 3- de su anillo de carbapenem, de la formula (1) en la cual los sustituyentes R a R5 tiene los significados que constan en ladescripcion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21053498 | 1998-07-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR019482A1 true AR019482A1 (es) | 2002-02-20 |
Family
ID=16590961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103683A AR019482A1 (es) | 1998-07-27 | 1999-07-27 | DERIVADOS SUSTITUIDOS DEL 2-IMIDAZO(5,1-b)TIAZOL-CARBAPENEM, LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS DERIVADOS PARA LAPREPARACION DE MEDICAMENTOS |
Country Status (10)
Country | Link |
---|---|
US (2) | US6458780B1 (es) |
EP (1) | EP1101766A4 (es) |
KR (1) | KR20010085302A (es) |
CN (1) | CN1315955A (es) |
AR (1) | AR019482A1 (es) |
AU (1) | AU771876B2 (es) |
BR (1) | BR9912490A (es) |
CA (1) | CA2338816A1 (es) |
ID (1) | ID29173A (es) |
WO (1) | WO2000006581A1 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010085302A (ko) * | 1998-07-27 | 2001-09-07 | 기따자또 이찌로 | 신규한 카르바페넴 유도체 |
JP2005231997A (ja) * | 2000-01-24 | 2005-09-02 | Meiji Seika Kaisha Ltd | カルバペネム誘導体の製造法 |
US6825187B2 (en) | 2000-01-26 | 2004-11-30 | Meiji Seika Kaisha, Ltd. | Carbapenem derivatives of quarternary salt type |
ES2228896T3 (es) * | 2000-01-26 | 2005-04-16 | Meiji Seika Kaisha, Ltd. | Nuevos derivados de carbapenem. |
HUP0400652A2 (hu) * | 2000-11-24 | 2004-06-28 | Meiji Seika Kaisha Ltd. | Új karbapenemszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP1582522A4 (en) * | 2002-12-13 | 2007-08-08 | Meiji Seika Kaisha | INTERMEDIARY FOR SUBSTITUTED CARBAPENEME DERIVED IN POSITION 2 AND METHOD OF PRODUCING THE SAME |
WO2006077919A1 (ja) | 2005-01-19 | 2006-07-27 | Meiji Seika Kaisha, Ltd. | イミダゾチアゾール誘導体およびその製造方法 |
JP2009544683A (ja) * | 2006-07-24 | 2009-12-17 | メルク シャープ エンド ドーム リミテッド | Markインヒビターとなるイミダゾチアゾール誘導体 |
WO2008085913A1 (en) * | 2007-01-04 | 2008-07-17 | Rib-X Pharmaceuticals, Inc. | Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
US20120022040A1 (en) * | 2008-12-01 | 2012-01-26 | Mutz Mitchell W | Antimicrobials |
PL221806B1 (pl) * | 2013-03-21 | 2016-05-31 | Inst Chemii Bioorg Polskiej Akademii Nauk | Sposób wprowadzania acetalowych i acetaloestrowych grup ochronnych oraz związki do realizacji tego sposobu |
US10526343B2 (en) * | 2018-03-26 | 2020-01-07 | University Of Sharjah | Heterocyclic systems and pharmaceutical applications thereof |
CN114790157B (zh) * | 2022-02-28 | 2024-06-21 | 开封大地农化生物科技有限公司 | 一种高含量乙蒜素的合成方法 |
CN114805280B (zh) * | 2022-05-17 | 2023-06-02 | 苏州华一新能源科技股份有限公司 | 碳酸亚乙烯酯的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996011932A1 (en) | 1994-10-14 | 1996-04-25 | Smithkline Beecham Plc | 2-(imidazol-4-yl)carbapeneme derivatives, intermediates thereof and use as antibacterials |
CA2189995C (en) | 1995-03-10 | 2001-01-23 | Kazuhiro Aihara | Novel carbapenem derivatives |
JP3527003B2 (ja) | 1995-03-10 | 2004-05-17 | 明治製菓株式会社 | 新規イミダゾ[5,1−b]チアゾール誘導体 |
JPH09249667A (ja) | 1996-01-12 | 1997-09-22 | Takeda Chem Ind Ltd | カルバペネム化合物、その製造法および剤 |
WO1998032760A1 (fr) * | 1997-01-28 | 1998-07-30 | Meiji Seika Kaisha, Ltd. | Nouveaux derives de carbapenem |
KR20010085302A (ko) * | 1998-07-27 | 2001-09-07 | 기따자또 이찌로 | 신규한 카르바페넴 유도체 |
ES2228896T3 (es) * | 2000-01-26 | 2005-04-16 | Meiji Seika Kaisha, Ltd. | Nuevos derivados de carbapenem. |
US6825187B2 (en) * | 2000-01-26 | 2004-11-30 | Meiji Seika Kaisha, Ltd. | Carbapenem derivatives of quarternary salt type |
HUP0400652A2 (hu) * | 2000-11-24 | 2004-06-28 | Meiji Seika Kaisha Ltd. | Új karbapenemszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
-
1999
- 1999-07-27 KR KR1020017001077A patent/KR20010085302A/ko not_active Application Discontinuation
- 1999-07-27 AU AU48024/99A patent/AU771876B2/en not_active Ceased
- 1999-07-27 CA CA002338816A patent/CA2338816A1/en not_active Abandoned
- 1999-07-27 ID IDW20010464A patent/ID29173A/id unknown
- 1999-07-27 WO PCT/JP1999/004025 patent/WO2000006581A1/ja not_active Application Discontinuation
- 1999-07-27 AR ARP990103683A patent/AR019482A1/es unknown
- 1999-07-27 BR BR9912490-4A patent/BR9912490A/pt not_active Application Discontinuation
- 1999-07-27 EP EP99931568A patent/EP1101766A4/en not_active Withdrawn
- 1999-07-27 CN CN99810341A patent/CN1315955A/zh active Pending
- 1999-07-27 US US09/744,583 patent/US6458780B1/en not_active Expired - Fee Related
-
2002
- 2002-08-14 US US10/217,670 patent/US6677331B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2338816A1 (en) | 2000-02-10 |
US20030149016A1 (en) | 2003-08-07 |
AU4802499A (en) | 2000-02-21 |
EP1101766A1 (en) | 2001-05-23 |
US6677331B2 (en) | 2004-01-13 |
BR9912490A (pt) | 2001-06-05 |
EP1101766A4 (en) | 2001-11-21 |
US6458780B1 (en) | 2002-10-01 |
WO2000006581A1 (fr) | 2000-02-10 |
KR20010085302A (ko) | 2001-09-07 |
ID29173A (id) | 2001-08-09 |
AU771876B2 (en) | 2004-04-01 |
CN1315955A (zh) | 2001-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR019482A1 (es) | DERIVADOS SUSTITUIDOS DEL 2-IMIDAZO(5,1-b)TIAZOL-CARBAPENEM, LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y EL USO DE DICHOS DERIVADOS PARA LAPREPARACION DE MEDICAMENTOS | |
CL2011000009A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de (diaza)- u (oxa-aza)-biciclo-octano en combinacion con un antibiotico de beta-lactamina; y el uso de la composicion para inhibir la produccion de beta-lactamasa en una terapia antibacteriana. (divisional de la solicitud 134-2003) | |
TR199901127T2 (xx) | Antibakteriyel etkili 6-O-ikameli ketolitler. | |
BRPI0921701B8 (pt) | Cefarosporina tendo um grupo catecol, seu uso e composição farmacêutica que a compreende | |
AR005597A1 (es) | Derivados de benzoxazina , composiciones farmaceuticas para el tratamiento de infecciones bacterianas, y metodo para la preparacion de dichos derivados. | |
UY25780A1 (es) | Nuevos antibióticos macrólidos | |
PA8524501A1 (es) | Antibioticos macrolidos | |
SV1999000194A (es) | Preparado farmaceuticio de moxifloxacina ref. lea 33327-sv | |
ES2129078T3 (es) | Preparacion farmaceutica que comprende un compuesto capaz de degradar los antibioticos beta-lactamicos y su utilizacion. | |
FI864825A (fi) | Cefalosporinderivat. | |
ATE480538T1 (de) | 2-arylmethylazetidincarbapenemderivate und deren herstellung | |
ES2136124T3 (es) | Derivados de carbapenem como antibioticos y sus productos intermedios. | |
SE8306882L (sv) | 7-karboximetoxifenylacetamido-3-cefem-derivat, forfaranden for framstellning derav och antibakteriella beredningar innehallande dem | |
CL2022000893A1 (es) | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 | |
CO4810376A1 (es) | Derivados de eritromicina triciclicos | |
AR121878A1 (es) | DERIVADOS DE BENZODIAZEPINA COMO PAM DE GABAA g1 | |
EA199800949A1 (ru) | Антибактериальные соединения карбапенема, содержащие их фармацевтические композиции и способы лечения | |
EP0760370A4 (en) | NEW CARBAPENEMIC DERIVATIVES | |
KR970702723A (ko) | 베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections) | |
PT1289998E (pt) | Novo processo para a preparacao de derivados de vinil-pirrolidinona cefalosporina | |
ATE192927T1 (de) | Neue cephem-derivate | |
ES2181159T3 (es) | Nuevos derivados de carbapenem. | |
HUP0400652A2 (hu) | Új karbapenemszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
PE20070342A1 (es) | 6-ALQUILIDEN-PENEM TRICICLICOS COMO INHIBIDORES DE ß-LACTAMASA Y COMBINACION DE ANTIBIOTICOS DE ß-LACTAMA: UN ANTIBIOTICO DE AMPLIO ESPECTRO | |
ES2070790B1 (es) | Derivados de carbapenem 1-beta-metil-2-tiolicos. |